Takafumi Etoh

Long-term management of moderate-to-severe atopic dermatitis with dupilumab and concomitant topical corticosteroids (LIBERTY AD CHRONOS): a 1-year, randomised, double-blinded, placebo-controlled, phase 3 trial

Andrew Blauvelt, Marjolein de Bruin‐Weller, Melinda Gooderham et al. · The Lancet · 2017 · 1.2K citations · Full text

Medicine, Dermatology, Immunology +17

Anti–Interleukin-31 Receptor A Antibody for Atopic Dermatitis

Thomas Ruzicka, Jon M. Hanifin, Masutaka Furue et al. · New England Journal of Medicine · 2017 · 587 citations · Full text

Medicine, Dermatology, Immunology +15

Nemolizumab in patients with moderate-to-severe atopic dermatitis: Randomized, phase II, long-term extension study

Kenji Kabashima, Masutaka Furue, Jon M. Hanifin et al. · Journal of Allergy and Clinical Immunology · 2018 · 243 citations · Full text

Medicine, Dermatology, Pharmacotherapy +14

Adalimumab in Japanese patients with moderate to severe chronic plaque psoriasis: Efficacy and safety results from a Phase II/III randomized controlled study

Akihiko Asahina, Hidemi Nakagawa, Takafumi Etoh et al. · The Journal of Dermatology · 2010 · 181 citations

Medicine, Dermatology, Pharmacotherapy +14

Clinical Practice Guidelines for the Management of Atopic Dermatitis 2016

Hidehisa Saeki, Takeshi Nakahara, Akio Tanaka et al. · The Journal of Dermatology · 2016 · 172 citations

Medicine, Dermatology, Immunology +17